Expert Care for Multiple Myeloma

Multiple Myeloma: Symptoms, Causes, Diagnosis, and Treatment | AIROC Hospitals

About Multiple Myeloma – Overview and Types

Multiple myeloma is a cancer that develops in plasma cells, a type of white blood cell found in the bone marrow that normally helps the body fight infection by producing antibodies. In multiple myeloma, abnormal plasma cells multiply uncontrollably and crowd out healthy blood cells, while also producing abnormal proteins that can affect the kidneys, bones, and immune system. At AIROC Hospitals, our hematology-oncology specialists offer advanced diagnostic and treatment options to manage multiple myeloma and help patients maintain the best possible quality of life.

Multiple myeloma often develops slowly, sometimes preceded by an earlier, symptom-free condition called monoclonal gammopathy of undetermined significance (MGUS). Because early-stage disease may not cause noticeable symptoms, diagnosis is sometimes made through routine blood tests before complications develop.

Types of Multiple Myeloma

Multiple myeloma and related plasma cell disorders are generally categorized as follows:

• Smoldering Multiple Myeloma – An early, asymptomatic stage where abnormal plasma cells are present but have not yet caused organ damage; closely monitored rather than immediately treated.
• Active (Symptomatic) Multiple Myeloma – The stage at which the disease causes noticeable symptoms and organ-related complications, requiring treatment.
• Solitary Plasmacytoma – A rare form in which a single tumor of abnormal plasma cells develops, either in the bone or in soft tissue, without widespread bone marrow involvement.
• Light Chain Myeloma – A subtype in which the abnormal plasma cells primarily produce light chain proteins rather than complete antibodies.

Identifying the specific stage and subtype of multiple myeloma is essential for determining the most appropriate treatment approach, and our specialists at AIROC Hospitals conduct thorough evaluation to guide personalized care.

 

Symptoms and Causes

Common Symptoms of Multiple Myeloma

Symptoms of multiple myeloma often relate to its effects on bones, blood, kidneys, and the immune system, and may include:

• Bone pain, especially in the back, hips, or ribs
• Frequent or unusual bone fractures
• Fatigue and weakness, often related to anemia
• Frequent infections due to a weakened immune system
• Excessive thirst and increased urination
• Nausea, loss of appetite, and constipation
• Confusion or difficulty thinking clearly
• Unexplained weight loss
• Numbness or weakness in the legs, if the spine is affected

Because these symptoms can resemble other conditions, particularly in older adults, persistent or unexplained bone pain, fatigue, or recurrent infections should be evaluated by a specialist.

Causes and Risk Factors

The exact cause of multiple myeloma is not fully understood, but several risk factors have been identified:

• Age: Most commonly diagnosed in adults over 60, with risk increasing significantly with age.
• Monoclonal Gammopathy of Undetermined Significance (MGUS): A precursor condition that carries a small but ongoing risk of progressing to multiple myeloma over time.
• Family History: Having a parent or sibling with multiple myeloma modestly increases individual risk.
• Sex: Slightly more common in men than women.
• Obesity: Associated with a higher risk of developing multiple myeloma.
• Race: More commonly diagnosed in individuals of Black African descent compared to other groups, for reasons not yet fully understood.
• Radiation and Chemical Exposure: Some studies suggest a possible link between certain occupational exposures and increased risk.

Understanding these risk factors helps our team at AIROC Hospitals guide appropriate monitoring, particularly for patients with a known precursor condition or relevant family history.

 

Diagnosis and Treatment

How Multiple Myeloma Is Diagnosed

At AIROC Hospitals, we use a comprehensive diagnostic approach to confirm multiple myeloma and assess its extent:

• Blood Tests: Including complete blood count, kidney function, calcium levels, and tests for abnormal proteins produced by myeloma cells.
• Urine Tests: Used to detect abnormal proteins (Bence Jones proteins) that may indicate multiple myeloma.
• Bone Marrow Biopsy: A key test that examines bone marrow tissue to confirm the presence and extent of abnormal plasma cells.
• Imaging Tests: X-rays, CT, MRI, or PET scans help identify bone damage or lesions caused by myeloma.
• Genetic and Molecular Testing: Performed on bone marrow samples to identify specific genetic changes that can guide treatment and provide prognostic information.

Treatment Options at AIROC Hospitals

Treatment for multiple myeloma is tailored to the disease stage, genetic profile, and the patient's overall health, and may include:

• Watchful Monitoring: For smoldering or asymptomatic myeloma, careful observation may be recommended before starting treatment.
• Targeted Therapy: Drugs designed to act on specific pathways involved in myeloma cell growth, forming a core part of modern treatment regimens.
• Immunotherapy: Includes antibody-based treatments that help the immune system recognize and destroy myeloma cells.
• Chemotherapy: Used in combination with other therapies to reduce the number of abnormal plasma cells.
• Corticosteroids: Often combined with other treatments to enhance effectiveness and help control the disease.
• Stem Cell Transplant: Considered for eligible patients, using high-dose therapy followed by transplantation of healthy stem cells to help restore normal blood cell production.
• Bone-Strengthening Medications: Used to help protect against bone damage and reduce the risk of fractures.
• Supportive Care: Includes management of pain, kidney function, and infection risk throughout treatment.

Our multidisciplinary team at AIROC Hospitals — including hematologists, transplant specialists, and supportive care providers — works closely together to design a treatment plan that manages the disease while addressing its impact on bones, kidneys, and overall health.

 

Prevention and Risk Factors

Because the exact cause of multiple myeloma remains unclear and many risk factors, such as age and genetics, cannot be changed, there is currently no established way to prevent it directly. However, the following can support early detection and overall health:

• Monitoring Known Precursor Conditions: Individuals diagnosed with MGUS should maintain regular follow-up to detect any early signs of progression.
• Awareness of Persistent Symptoms: Ongoing bone pain, unexplained fatigue, or recurrent infections should not be ignored, particularly in older adults.
• Prompt Medical Evaluation: Early diagnosis allows for timely treatment planning and helps prevent complications such as bone fractures or kidney damage.
• Maintaining a Healthy Weight: May help modestly reduce risk, given the association between obesity and multiple myeloma.
• Routine Blood Testing for High-Risk Individuals: Those with a family history of multiple myeloma may benefit from discussing appropriate monitoring with their doctor.

At AIROC Hospitals, we emphasize the importance of timely evaluation for persistent bone pain or unexplained symptoms, as early diagnosis and monitoring play a key role in successfully managing multiple myeloma and preventing complications.

 

This content is intended for informational purposes only and does not substitute professional medical advice. Please consult a specialist at AIROC Hospitals for personalized diagnosis and treatment recommendations.